Vlad Vitoc
Director Ejecutivo en MAIA BIOTECHNOLOGY, INC. .
Fortuna: 5 M $ al 31/05/2024
Perfil
Dr. Vlad Vitoc is a Chairman, President & Chief Executive Officer at MAIA Biotechnology, Inc. and a Chief Executive Officer & Director at DGD Pharmaceuticals Corp.
He is on the Board of Directors at DGD Pharmaceuticals Corp.
He received his MBA from the University of South Carolina and a doctorate degree from Iuliu Hatieganu University of Medicine & Pharmacy.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
MAIA BIOTECHNOLOGY, INC.
4.67% | 26/04/2024 | 1 019 121 ( 4.67% ) | 5 M $ | 31/05/2024 |
Cargos activos de Vlad Vitoc
| Empresas | Cargo | Inicio |
|---|---|---|
| MAIA BIOTECHNOLOGY, INC. | Director Ejecutivo | 03/08/2018 |
DGD Pharmaceuticals Corp.
 DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Director Ejecutivo | - |
Formación de Vlad Vitoc.
| Iuliu Hatieganu University of Medicine & Pharmacy | Doctorate Degree |
| University of South Carolina | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MAIA BIOTECHNOLOGY, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
DGD Pharmaceuticals Corp.
DGD Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology DGD Pharmaceuticals engages in the development of drug for cancer therapies. It offers DGD1202, targets cancer cell and help prevent to mutate into EGFR. The company was founded by Mukesh Nyati and is headquartered in Chicago, IL. | Health Technology |
- Bolsa de valores
- Insiders
- Vlad Vitoc
